Maria Velegraki

5PUBLICATIONS
53CO-AUTHORS
Solid tumoursPredictive and prognostic markersRegenerative medicine (incl. stem cells)Cancer geneticsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 20, 2026
RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma.

|Mar 28, 2026
ZFP148 is a transcriptional repressor of cytolytic effector CD8+ T cell differentiation.

Tong Xiao, Xingyu Chen, No-Joon Song

|Aug 26, 2022
Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS.

Maria Velegraki, Andrew Stiff, Helen A Papadaki

|Apr 14, 2022
Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer.

Hyunwoo Kwon, Johanna M Schafer, No-Joon Song

|Mar 18, 2022
Transforming growth factor-β1 in regulatory T cell biology.

Joshua M Moreau, Maria Velegraki, Chelsea Bolyard

Pageof 1

Frequent Collaborators

4 joint publications

Zihai Li

2 joint publications

Anjun Ma

2 joint publications

Qin Ma

1 joint publications

Joshua M Moreau